DE60320793D1 - Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur ametischen mittels in ein gewebe - Google Patents
Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur ametischen mittels in ein gewebeInfo
- Publication number
- DE60320793D1 DE60320793D1 DE60320793T DE60320793T DE60320793D1 DE 60320793 D1 DE60320793 D1 DE 60320793D1 DE 60320793 T DE60320793 T DE 60320793T DE 60320793 T DE60320793 T DE 60320793T DE 60320793 D1 DE60320793 D1 DE 60320793D1
- Authority
- DE
- Germany
- Prior art keywords
- therapeutic
- diagnostic
- ametic
- nurses
- codes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/86—Products or compounds obtained by genetic engineering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36726102P | 2002-03-26 | 2002-03-26 | |
PCT/IL2003/000241 WO2003079967A2 (en) | 2002-03-26 | 2003-03-20 | Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60320793D1 true DE60320793D1 (de) | 2008-06-19 |
Family
ID=28454843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60320793T Expired - Lifetime DE60320793D1 (de) | 2002-03-26 | 2003-03-20 | Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur ametischen mittels in ein gewebe |
Country Status (7)
Country | Link |
---|---|
US (2) | US7611723B2 (de) |
EP (1) | EP1519755B1 (de) |
AT (1) | ATE394125T1 (de) |
AU (1) | AU2003215878A1 (de) |
DE (1) | DE60320793D1 (de) |
IL (1) | IL164191A0 (de) |
WO (1) | WO2003079967A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001295850A1 (en) | 2000-09-28 | 2002-04-08 | Nanocyte Inc. | Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
US7632522B2 (en) | 2000-09-28 | 2009-12-15 | Nanocyte Inc. | Use of stinging cells/capsules for the delivery of active agents to keratinous substances |
US20060222656A1 (en) * | 2005-04-01 | 2006-10-05 | University Of Maryland, Baltimore | MAGE-A3/HPV 16 peptide vaccines for head and neck cancer |
US7611723B2 (en) | 2002-03-26 | 2009-11-03 | Nanocyte Inc. | Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
WO2005040388A2 (en) * | 2003-08-22 | 2005-05-06 | Nucleonics Inc. | Eukariotic expression systems for expression of inhibitory rna in multiple intracellular compartments |
ES2612752T3 (es) | 2003-12-18 | 2017-05-18 | Metronom Health, Inc. | Biosensor implantable y métodos de uso del mismo |
US8834862B2 (en) | 2005-04-19 | 2014-09-16 | Nanocyte Inc. | Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent |
WO2007007316A1 (en) | 2005-07-07 | 2007-01-18 | Cbd Technologies Ltd. | Compositions and methods comprising stinging capsules/cells for delivering a biologically active agent into a plant cell |
DE102007035238A1 (de) * | 2007-07-27 | 2009-01-29 | Christian-Albrechts-Universität Zu Kiel | Biologisches Effektmonitoring mittels transgener Hydra |
WO2017142993A1 (en) * | 2016-02-16 | 2017-08-24 | Manus Biosynthesis, Inc. | Secondary metabolite screening system |
WO2018178969A1 (en) * | 2017-03-28 | 2018-10-04 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Transformed organisms with stinging cells expressing an exogenous protein of interest |
WO2024006793A1 (en) * | 2022-06-29 | 2024-01-04 | Battelle Memorial Institute | Nematocysts as natural microinjectors |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US614960A (en) * | 1898-11-29 | Hair-clipper | ||
US3321188A (en) | 1965-10-04 | 1967-05-23 | Broadway Imp S | Paint mixing device |
NL154600B (nl) * | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
NL154598B (nl) * | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
NL154599B (nl) * | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
US3901654A (en) * | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
US3853987A (en) * | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
US3867517A (en) * | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
NL171930C (nl) * | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
US3850578A (en) * | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
US3935074A (en) * | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
US3996345A (en) * | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4034074A (en) * | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
US3984533A (en) * | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
US4098876A (en) * | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
US4879219A (en) * | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
US5011771A (en) * | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
US4666828A (en) * | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
US4801531A (en) * | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
US5459047A (en) | 1986-07-01 | 1995-10-17 | Genetics Institute, Inc. | BMP-6 proteins |
US5272057A (en) * | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
US5073488A (en) * | 1988-11-29 | 1991-12-17 | Minnesota Mining And Manufacturing Company | Rapid method for determining efficacy of a sterilization cycle and rapid read-out biological indicator |
US5192659A (en) * | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
US5162378A (en) * | 1990-04-20 | 1992-11-10 | Revlon Consumer Products Corporation | Silicone containing water-in-oil microemulsions having increased salt content |
US5885260A (en) * | 1991-05-30 | 1999-03-23 | Mehl, Sr.; Thomas L. | Freeze-dried liposome delivery system for application of skin treatment agents |
US5641508A (en) | 1994-01-13 | 1997-06-24 | Anticancer, Inc. | Method for delivering melanin to hair follicles |
US5281521A (en) * | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
US5362442A (en) * | 1993-07-22 | 1994-11-08 | 2920913 Canada Inc. | Method for sterilizing products with gamma radiation |
US5624803A (en) * | 1993-10-14 | 1997-04-29 | The Regents Of The University Of California | In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom |
US5885211A (en) * | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
FR2729855A1 (fr) | 1995-01-26 | 1996-08-02 | Oreal | Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue |
US6416960B1 (en) * | 1996-08-08 | 2002-07-09 | Prolume, Ltd. | Detection and visualization of neoplastic tissues and other tissues |
DK1314400T3 (da) | 1996-12-31 | 2007-10-15 | Altea Therapeutics Corp | Mikroporering af væv til levering af bioaktive midler |
US6132747A (en) * | 1997-05-29 | 2000-10-17 | Nidaria Technology Ltd. | Compositions and methods for inhibiting nematocyst discharge |
US6338837B1 (en) * | 1997-05-29 | 2002-01-15 | Nidaria Technology Ltd. | Compositions and methods for inhibiting nematocyst discharge |
US6406709B1 (en) * | 1997-05-29 | 2002-06-18 | Nidaria Technology Ltd. | Method for inhibiting nematocyst discharge |
US6173202B1 (en) | 1998-03-06 | 2001-01-09 | Spectrx, Inc. | Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
US6022316A (en) * | 1998-03-06 | 2000-02-08 | Spectrx, Inc. | Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications |
WO1999044507A1 (en) | 1998-03-06 | 1999-09-10 | Spectrx, Inc. | Integrated tissue poration, fluid harvesting and analysis device, and method therefor |
US6630001B2 (en) * | 1998-06-24 | 2003-10-07 | International Heart Institute Of Montana Foundation | Compliant dehyrated tissue for implantation and process of making the same |
ATE413899T1 (de) | 1998-07-14 | 2008-11-15 | Altea Therapeutics Corp | Transdermale transportvorrichtung zum kontrollierten entfernen von biologischen membranen durch pyrotechnische ladung |
CA2338292A1 (en) | 1998-07-21 | 2000-02-03 | Jonathan A. Eppstein | Fluid management in a continuous fluid collection and sensor device |
DE69937738D1 (de) | 1998-07-21 | 2008-01-24 | Altea Therapeutics Corp | Verfahren und vorrichtung zur kontinuierlichen überwachung eines analyten |
JP4531983B2 (ja) | 1998-09-10 | 2010-08-25 | アルテア セラピューティクス コーポレイション | 検体の検出および/または連続的監視用の属性の補償 |
AU1728701A (en) | 1999-11-29 | 2001-06-04 | Nidaria Technology Ltd. | A composition and method for inhibiting polar capsule discharge and protecting asubject from nematocyst sting |
DE60107408T2 (de) * | 2000-04-17 | 2005-12-22 | Organ Recovery Systems, Inc., Des Plaines | Neues aufwärmverfahren für cryokonservierte proben |
AU2001295850A1 (en) * | 2000-09-28 | 2002-04-08 | Nanocyte Inc. | Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
US7632522B2 (en) | 2000-09-28 | 2009-12-15 | Nanocyte Inc. | Use of stinging cells/capsules for the delivery of active agents to keratinous substances |
US20070281037A9 (en) | 2000-09-28 | 2007-12-06 | Nanocyte Inc. | Sterile preparations and compositions including stinging capsules and methods of producing and using same |
US7611723B2 (en) | 2002-03-26 | 2009-11-03 | Nanocyte Inc. | Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
US20030189850A1 (en) * | 2002-04-09 | 2003-10-09 | Toyo Boseki Kabushiki Kaisha | Cell array system |
JP2004344036A (ja) * | 2003-05-21 | 2004-12-09 | Fujitsu Ltd | 物質導入装置及び物質導入システム |
US20050181978A1 (en) | 2003-11-20 | 2005-08-18 | Rasmus Rojkjaer | Therapeutic use of factor XI |
US20060099272A1 (en) | 2004-11-05 | 2006-05-11 | Nanocyte Inc. | Compositions and kits including dehydrated stinging capsules and methods of producing and using same |
WO2006090367A2 (en) | 2005-02-24 | 2006-08-31 | Xeround Systems Ltd. | Method and apparatus for distributed data management in a switching network |
US8834862B2 (en) | 2005-04-19 | 2014-09-16 | Nanocyte Inc. | Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent |
-
2003
- 2003-03-20 US US10/507,692 patent/US7611723B2/en not_active Expired - Fee Related
- 2003-03-20 AU AU2003215878A patent/AU2003215878A1/en not_active Abandoned
- 2003-03-20 EP EP03744968A patent/EP1519755B1/de not_active Expired - Lifetime
- 2003-03-20 DE DE60320793T patent/DE60320793D1/de not_active Expired - Lifetime
- 2003-03-20 AT AT03744968T patent/ATE394125T1/de not_active IP Right Cessation
- 2003-03-20 IL IL16419103A patent/IL164191A0/xx unknown
- 2003-03-20 WO PCT/IL2003/000241 patent/WO2003079967A2/en active IP Right Grant
-
2009
- 2009-10-14 US US12/588,368 patent/US8337868B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2003079967A2 (en) | 2003-10-02 |
EP1519755B1 (de) | 2008-05-07 |
EP1519755A4 (de) | 2006-11-22 |
US20060039897A1 (en) | 2006-02-23 |
US20100111869A1 (en) | 2010-05-06 |
US8337868B2 (en) | 2012-12-25 |
US7611723B2 (en) | 2009-11-03 |
WO2003079967A3 (en) | 2005-02-03 |
AU2003215878A8 (en) | 2003-10-08 |
IL164191A0 (en) | 2005-12-18 |
EP1519755A2 (de) | 2005-04-06 |
ATE394125T1 (de) | 2008-05-15 |
AU2003215878A1 (en) | 2003-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60320793D1 (de) | Nesselzellen mit expression eines exogenen polynucleotids, das ein therapeutisches, diagnostisches oder kosmetisches mittel kodiert, und diese nesselzellen verwendende verfahren, zusammensetzungen und vorrichtungen oder daraus gewonnene kapseln zur ametischen mittels in ein gewebe | |
Lademann et al. | Risk assessment of the application of tissue-tolerable plasma on human skin | |
Seaton et al. | Investigation of the mechanism of action of nonablative pulsed‐dye laser therapy in photorejuvenation and inflammatory acne vulgaris | |
HRP20120887T1 (en) | Adherent cells from adipose or placenta tissues and use thereof in therapy | |
ATE418316T1 (de) | Mittel zur oxidativen behandlung, insbesondere in transparenter gelform | |
ATE395924T1 (de) | Wiederherstellung zerstörten gewebes mit hilfe von multipotenten zellen | |
DE60234469D1 (de) | Hämostatische garnitur, verfahren zum zubereiten eines hämostatischen mittels und verfahren zur blutstillung | |
ATE444773T1 (de) | Mikroprojektionsanordnung mit einem überzug, der ein vorteilhaftes mittel enthält | |
ATE425732T1 (de) | Formulierungen mit ceramiden und/oder pseudoceramiden und (alpha-)bisabolol zur behandlung von hautschaden | |
DE60331740D1 (de) | Gerät zur abdichtung von punktionsstellen in blutgefässen | |
AL‐Dhalimi et al. | Subcision for treatment of rolling acne scars in Iraqi patients: a clinical study | |
CN115379877A (zh) | 调制波形护理装置及方法 | |
CN111973483A (zh) | 一种用于自体修复的美容注射液及其使用方法 | |
CN105534784A (zh) | 一种自体胶原紧致组合物 | |
FR2915397B1 (fr) | Composition pharmaceutique et/ou cosmetique contenant des principes actifs activateurs de l'aconitase | |
CN104474577B (zh) | 一种激光美容术后敷料及制备方法 | |
BRPI0408244A (pt) | composição de cuidado pessoal, e, processo para fabricar uma composição de cuidado pessoal | |
DE602007005664D1 (de) | Verwendung eines quinoa-extrakts als kosmetisches und pharmazeutisches schlankheitsmittel und/oder als mittel zur verhinderung der formierung neuer fette im menschlichen körper | |
Suondoh et al. | Distribution of anterolateral thigh flap perforator vessels and its clinical applications in Malaysian population | |
CN204502153U (zh) | 手心治疗仪及手部治疗仪 | |
BR0316025A (pt) | Lenço para melhorar a saúde da pele, produto para melhorar a saúde da pele e método para aumento da concentração intracelular de ceramidas | |
Dogan | Introductory Chapter: An Overview of Wound Healing | |
DE50301467D1 (de) | Medizinisches Arbeitsmittel | |
Kim | Wounds | |
Banerjee | " MI" caries management-an overview |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |